Explore more publications!

Tech Press of Togo: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Press of Togo.

Press releases published on November 4, 2025

RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
Revolution Medicines to Participate in November 2025 Investor Conferences
Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update
Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025
Astera Labs Announces Financial Results for the Third Quarter of Fiscal Year 2025
Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study
ImmuCell Announces Onboarding of New CEO and Related Management Changes
Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025
Biomea Fusion Reports Third Quarter 2025 Financial Results and Corporate Highlights
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance
Key Tronic Corporation Announces Results for The First Quarter of Fiscal Year 2026
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
Spyre Therapeutics Announces Positive Interim Phase 1 Results for SPY003, Its Novel, Half-Life Extended anti-IL-23 Antibody
Cardiff Oncology to Participate in Two Upcoming Investor Conferences
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions